13F HOLDINGS REPORT
Ally Bridge Group (NY) LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0000950123-25-008419
Total Value
$120.2M
Positions
24
Other Managers
1
Confidential Omitted
No
Holdings (24)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VERONA PHARMA PLC | 925050106 | 160,701 | $15.2M | 12.65% |
| 2 | SOLENO THERAPEUTICS INC | SLNO | 178,819 | $15.0M | 12.47% |
| 3 | LENZ THERAPEUTICS INC | LENZ | 343,322 | $10.1M | 8.37% |
| 4 | MERUS N V | N5749R100 | 140,208 | $7.4M | 6.14% |
| 5 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 1,600 | $5.8M | 4.84% |
| 6 | ENLIVEN THERAPEUTICS INC | ELVN | 281,394 | $5.6M | 4.70% |
| 7 | ORIC PHARMACEUTICALS INC | ORIC | 485,629 | $4.9M | 4.10% |
| 8 | REPLIMUNE GROUP INC | REPL | 528,491 | $4.9M | 4.09% |
| 9 | TARSUS PHARMACEUTICALS INC | TARS | 121,182 | $4.9M | 4.08% |
| 10 | INSMED INC | INSM | 47,710 | $4.8M | 4.00% |
| 11 | MIND MEDICINE MINDMED INC | 60255C885 | 726,172 | $4.7M | 3.92% |
| 12 | GERON CORP | GERN | 3,251,475 | $4.6M | 3.81% |
| 13 | COMPASS PATHWAYS PLC | CMPS | 1,485,000 | $4.2M | 3.46% |
| 14 | CENTESSA PHARMACEUTICALS PLC | CNTA | 293,986 | $3.9M | 3.21% |
| 15 | AVIDITY BIOSCIENCES INC | 05370A108 | 132,744 | $3.8M | 3.14% |
| 16 | SOLID BIOSCIENCES INC | SLDB | 724,000 | $3.5M | 2.93% |
| 17 | LEXEO THERAPEUTICS INC | LXEO | 867,302 | $3.5M | 2.90% |
| 18 | PRAXIS PRECISION MEDICINES I | PRAX | 80,880 | $3.4M | 2.83% |
| 19 | TECTONIC THERAPEUTIC INC | TECX | 163,683 | $3.3M | 2.71% |
| 20 | KORRO BIO INC | KRRO | 154,223 | $1.9M | 1.60% |
| 21 | WHITEHAWK THERAPEUTICS INC | WHWK | 817,939 | $1.5M | 1.27% |
| 22 | ATYR PHARMA INC | ATYR | 287,720 | $1.5M | 1.21% |
| 23 | MONOPAR THERAPEUTICS INC | MNPR | 34,537 | $1.2M | 1.03% |
| 24 | PROMIS NEUROSCIENCES INC | PMN | 1,334,428 | $645,596 | 0.54% |